Lee Mozessohn
Toronto, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 52 publications
Venetoclax and hypomethylating agents versus other therapies: an international, multicenter, retrospective cohort chart review study.
Journal: Leukemia & lymphoma
Published: July 29, 2026
Management of Acute Myeloid Leukemia in Older Patients: An Updated Canadian Consensus.
Journal: Current oncology (Toronto, Ont.)
Published: May 07, 2026
A Prospective Population-Based Study of Chimeric Antigen Receptor T-Cell Therapy for Patients with Diffuse Large B-Cell Lymphoma.
Journal: Current oncology (Toronto, Ont.)
Published: March 30, 2026
Interfollicular Plasmacytosis and Hyperplastic Germinal Centers in Idiopathic Multicentric Castleman Disease, Idiopathic Plasmacytic Lymphadenopathy Subtype.
Journal: American journal of hematology
Published: March 04, 2026
Comparative effectiveness of chimeric antigen receptor (CAR) T-cell therapy versus historical controls in patients with relapse/refractory aggressive B-cell lymphoma: An indirect treatment comparison in the real-world setting.
Journal: British journal of haematology
Published: February 25, 2026
Evaluating the incidence and predictors of chronic opioid use in early survivorship for patients with diffuse large B-cell lymphoma.
Journal: Journal of the National Cancer Institute
Published: January 19, 2026
American Society of Hematology 2026 guidelines for frontline management of acute lymphoblastic leukemia in adolescents and young adults.
Journal: Blood advances
Published: October 06, 2025
Outcomes following exposure to drug interactions with ibrutinib in patients with chronic lymphocytic leukaemia.
Journal: British journal of haematology
Published: April 28, 2025
Last Updated: 09/26/2026